These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30041690)

  • 1. Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol.
    Mato EPM; Guewo-Fokeng M; Faadiel Essop M; Owira PMO
    Syst Rev; 2018 Jul; 7(1):105. PubMed ID: 30041690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review.
    Mofo Mato EP; Guewo-Fokeng M; Essop MF; Owira PMO
    Medicine (Baltimore); 2018 Jul; 97(27):e11349. PubMed ID: 29979413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of OCT1 influence glycemic response to metformin in Han Chinese patients with type-2 diabetes mellitus in Shanghai.
    Zhou Y; Ye W; Wang Y; Jiang Z; Meng X; Xiao Q; Zhao Q; Yan J
    Int J Clin Exp Pathol; 2015; 8(8):9533-42. PubMed ID: 26464716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
    Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
    Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis.
    Peng A; Gong C; Xu Y; Liang X; Chen X; Hong W; Yan J
    Front Public Health; 2023; 11():1183879. PubMed ID: 37546319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.
    Shikata E; Yamamoto R; Takane H; Shigemasa C; Ikeda T; Otsubo K; Ieiri I
    J Hum Genet; 2007; 52(2):117-122. PubMed ID: 17111267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
    Reséndiz-Abarca CA; Flores-Alfaro E; Suárez-Sánchez F; Cruz M; Valladares-Salgado A; Del Carmen Alarcón-Romero L; Vázquez-Moreno MA; Wacher-Rodarte NA; Gómez-Zamudio JH
    J Clin Pharmacol; 2019 Oct; 59(10):1384-1390. PubMed ID: 31012983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.
    Li S; Xu B; Fan S; Kang B; Deng L; Chen D; Yang B; Tang F; He Z; Xue Y; Zhou JC
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1107-1117. PubMed ID: 36065506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Polymorphisms of
    Chang HH; Hsueh YS; Cheng YW; Ou HT; Wu MH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.
    Dujic T; Causevic A; Bego T; Malenica M; Velija-Asimi Z; Pearson ER; Semiz S
    Diabet Med; 2016 Apr; 33(4):511-4. PubMed ID: 26605869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.
    Berstein LM; Iyevleva AG; Vasilyev D; Poroshina TE; Imyanitov EN
    Cell Cycle; 2013 Dec; 12(23):3681-8. PubMed ID: 24145224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.
    Peter EL; Deyno S; Mtewa A; Kasali FM; Nagendrappa PB; Sesaazi D; Tolo CU; Ogwang PE
    Syst Rev; 2018 Nov; 7(1):192. PubMed ID: 30442186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous use of metformin on cardiovascular outcomes in patients with type 2 diabetes after acute myocardial infarction: A protocol for systematic review and meta-analysis.
    Shen C; Tan S; Yang J
    Medicine (Baltimore); 2021 Apr; 100(15):e25353. PubMed ID: 33847633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.
    Dujic T; Zhou K; Yee SW; van Leeuwen N; de Keyser CE; Javorský M; Goswami S; Zaharenko L; Hougaard Christensen MM; Out M; Tavendale R; Kubo M; Hedderson MM; van der Heijden AA; Klimčáková L; Pirags V; Kooy A; Brøsen K; Klovins J; Semiz S; Tkáč I; Stricker BH; Palmer C; 't Hart LM; Giacomini KM; Pearson ER
    Clin Pharmacol Ther; 2017 Jun; 101(6):763-772. PubMed ID: 27859023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function.
    Chen L; Takizawa M; Chen E; Schlessinger A; Segenthelar J; Choi JH; Sali A; Kubo M; Nakamura S; Iwamoto Y; Iwasaki N; Giacomini KM
    J Pharmacol Exp Ther; 2010 Oct; 335(1):42-50. PubMed ID: 20639304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
    Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
    Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.
    Raj GM; Mathaiyan J; Wyawahare M; Priyadarshini R
    Drug Metab Pers Ther; 2018 Dec; 33(4):175-185. PubMed ID: 30433870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by
    Dawed AY; Zhou K; van Leeuwen N; Mahajan A; Robertson N; Koivula R; Elders PJM; Rauh SP; Jones AG; Holl RW; Stingl JC; Franks PW; McCarthy MI; 't Hart LM; Pearson ER;
    Diabetes Care; 2019 Jun; 42(6):1027-1033. PubMed ID: 30885951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09).
    Joerger M; van Schaik RH; Becker ML; Hayoz S; Pollak M; Cathomas R; Winterhalder R; Gillessen S; Rothermundt C
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):167-72. PubMed ID: 25753371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.